nQuery

Koneksa is a leading digital biomarker company for the pharmaceutical and biotechnology industries, specializing in developing, testing, and validating digital biomarkers to help clients understand the impact of their treatments on patients. Founded in 2013, Koneksa provides end-to-end remote clinical trial support, leveraging digital health technology, therapeutic expertise, and rapid patient-friendly remote data collection to gain better insights into patient health. Their validated, novel data algorithms are ready to deploy in treatment development programs, enabling the identification of signals earlier and faster than traditional measures. Koneksa's cloud-based SaaS platform allows multiple endpoints to be fed in real-time, giving immediate access to data and empowering confident, cost-saving decisions early in trials. The platform's ability to collect high-volume remote data with increased frequency offers ecologically valid measures and opportunities to reduce sample size.

Available in multiple modalities, our market-leading solution for patient randomization and trial supply management is the most configurable and customizable Interactive Response Technology available. From Phase I through to IV, simple designs to complex adaptive trials, IXRS®3 will easily accommodate any permutation of study objectives, and with it comes a team of professional biostatisticians, language and integration experts who are at the ready 24/7. The site-facing functions are designed to automate steps that are prone to human error. Site users have the freedom to make data corrections without the need to call a Help Desk for support or fear of deviating from trial compliance. Easy-to-read visual tools instead of hundreds of pages of specifications and legalese. View and react to each stage of the software build along the way, eliminating delivery surprises.